What mid-market businesses get wrong about AI adoption
Most mid-market businesses are not behind on AI because they lack ambition. They are behind because they are copying the wrong playbook.
They watch what large enterprises announce, read the same vendor whitepapers and conclude that AI adoption means buying a platform, standing up a Centre of Excellence and waiting for ROI to materialise. That approach works poorly even at scale. At the £500m to £1.5bn revenue tier, it tends to produce a funded experiment with no clear owner, no production deployment and a quiet write-down eighteen months later.
The mistake is structural, not technological. Mid-market organisations have real commercial leverage points - faster decisions, less organisational drag, closer leadership proximity to operations - but they routinely sacrifice those advantages by treating AI adoption as an IT programme rather than a commercial initiative.
This article names the four most common errors we see at this tier, explains why they persist and sets out what a more effective approach looks like in practice.
Confusing AI adoption with AI procurement
The most common failure mode is treating adoption as a buying decision. A CFO sees a compelling vendor demo, a budget gets allocated, a contract gets signed. Six months later, a tool exists but behaviour has not changed, decisions are not different and the business case is quietly orphaned.
Procurement is not adoption. Adoption is the point at which a changed system produces a changed decision, which produces a changed outcome. Everything before that point is setup.
A useful diagnostic question: can you name one commercial decision made last quarter that was materially different because of your current AI investment? If the answer is no, you have a procurement, not an adoption.
This distinction matters especially at the mid-market tier because resources are finite. A business with a £2m technology budget cannot absorb the experimental losses that a FTSE 50 company can. Every investment needs a clearer line to commercial impact.
The right entry point is not a platform. It is a problem. A distribution business, for example, might have a margin leakage issue in their pricing function - account managers applying inconsistent discounts across a large customer base. That is a defined problem with measurable cost. AI applied to that problem, with clear decision rules and accountable owners, produces traceable value. A general-purpose AI platform deployed without that focus produces activity.
Underestimating the data readiness gap
Senior leaders frequently underestimate how much foundational data work sits between their current state and any meaningful AI capability. This is not a criticism - the gap is genuinely hard to see from the outside, and vendors rarely surface it during the sales process.
The pattern we see repeatedly: a business has been running an ERP for a decade, has a CRM with reasonable coverage and generates good financial reporting. Leadership assumes the data infrastructure is there. It is not. The ERP has been customised and re-customised. The CRM data is inconsistently populated. The commercial and operational datasets have never been meaningfully joined. Nobody has ever built a single clean entity model for the customer.
At this point, deploying a sophisticated AI model is like installing a high-performance engine in a car with no fuel lines. The capability exists but it cannot connect to what it needs.
A realistic data readiness assessment for an organisation at this revenue tier typically surfaces three to five significant remediation items before any AI layer can be effectively deployed. This is not a reason to delay indefinitely - but it is a reason to be honest about sequencing. The businesses that move fastest on AI are usually the ones that invested earliest in data governance and integration, often before AI was the stated objective.
Delegating AI strategy to technology functions alone
AI strategy that lives entirely within IT or technology functions will underperform. The reason is simple: the people closest to the commercial problems are not in the room.
This is a governance issue more than a capability issue. CIOs and CTOs at mid-market firms are often highly capable, but they are managing infrastructure, vendor relationships and security obligations at the same time as being asked to lead AI transformation. That combination of responsibilities produces caution and incrementalism, which are the correct instincts for running infrastructure and the wrong instincts for driving commercial AI adoption.
The CFO and COO have more direct visibility of the decisions that AI should be augmenting - pricing, demand planning, credit risk, supplier negotiation, operational throughput. When those leaders are not actively shaping the AI agenda, you get technically coherent deployments that solve the wrong problems.
A practical structural fix: create a small AI steering group that includes the commercial leadership alongside technology. Not a large governance committee - a working group of four to six people with a mandate to identify, prioritise and sponsor specific use cases, each with a defined owner and a measurable output. Keep the mandate narrow and the timeline short. Six-month cycles work better than annual planning at this pace of change.
Treating AI as a future capability rather than a current one
There is a version of AI strategy that is entirely forward-facing. It is full of roadmaps, maturity models and multi-year transformation horizons. It is also, in practice, a way of deferring the hard question of what changes now.
Mid-market businesses at the £500m to £1.5bn tier already have live use cases available to them. Natural language querying of commercial data, automated insight generation on top of existing reporting, AI-assisted contract review, predictive churn modelling on customer data you already hold - none of these require fundamental infrastructure change. They require clear ownership, a pilot scope and willingness to act on the output.
The cost of treating AI as a future capability is not just deferred benefit. It is competitive displacement. In sectors like distribution, business services and ecommerce, the firms that have moved from experimentation to production deployment in the last eighteen months have started to see measurable differences in decision speed and cost structure. They are not announcing it loudly. But they are repricing, reallocating and outmanoeuvring more slowly-moving competitors.
The organisations most at risk are those that have been planning AI adoption for two years without deploying anything in production. Planning without deployment does not build capability. It builds familiarity with the language of AI, which is not the same thing.
A practical step right now: identify one operational or commercial decision that is made repeatedly, at volume, with imperfect information. That is your first deployment candidate. Scope it tightly, build it properly and measure it honestly. That single production deployment will teach you more about what AI can do for your business than any amount of vendor evaluation.
What to do before the end of this quarter
If you are a senior leader at a mid-market business and you cannot point to a production AI deployment with a measurable commercial output, the question is not whether to act. The question is where to start without wasting the budget.
The sequencing that works: start with a structured diagnostic that maps your actual data assets against your highest-value commercial decisions, identifies the two or three use cases with the clearest path to deployment and surfaces the data or governance gaps that need addressing first. That diagnostic should take four to six weeks and cost a fraction of any platform investment.
What you cannot afford is another quarter of evaluation. The gap between organisations that are deploying and those still planning is widening, and at this revenue tier, the margin for error is smaller than you think.
If you want to understand where your business genuinely sits on AI readiness and which use cases offer the fastest path to commercial value, speak to Rodan about a diagnostic engagement.
